Ann: Company Presentation, page-34

Looking like an amazing 2020. We can now see a plan around how much further beyond the Dementia market things will move, with entry into Home Care and Hospitals. A clear pathway around the expansion.

The pricing has changed slightly. It seems they are maximizing market penetration which is the priority. Due to the product being sticky and having no churn, going for market penetration rather at a lower price makes sense. In the future they will have an advantage around pricing.

The exchange price for the director shares is necessary due to the volume of shares changing hands. We will see how it goes in the short term.